At. Bruinvels et al., A COMPARATIVE AUTORADIOGRAPHIC STUDY OF 5-HT1D BINDING-SITES IN HUMANAND GUINEA-PIG BRAIN USING DIFFERENT RADIOLIGANDS, Molecular brain research, 21(1-2), 1994, pp. 19-29
Quantitative receptor autoradiography was used to examine the 5-hydrox
ytryptamine (5-HT, serotonin) binding sites labelled with tonin-5-O-ca
rboxymethyl-glycyl-[I-125]tyrosinamide ([I-125]GTI) in human and guine
a-pig brain. Competition experiments using 5-carboxamidotryptamine hyd
ropyrid-4-yl)pyrrolo[3,2,b]pyrid-5-one(CP93129) and sumatriptan reveal
ed monophasic displacement curves in various brain regions, suggesting
that a homogeneous population of 5-HT1D binding sites was labelled. D
isplacement of [H-3]5-HT (in the presence of 100 nM 8-hydroxy-2(N-dipr
opylamino)tetralin (8-OH-DPAT) and 100 nM mesulergine) with unlabelled
GTI resulted in monophasic competition curves in substantia nigra, gl
obus pallidus and central gray. In contrast, biphasic displacement was
observed in hippocampus, nucleus accumbens, claustrum, caudate-putame
n and frontal cortex. The distribution of [I-125]GTI sites was compare
d to that of [H-3]5-HT binding sites (under so-called '5-HT1D conditio
ns', i.e. in the presence of 100 nM 8-OH-DPAT and 100 nM mesulergine,
in order to block 5-HT1A and 5-HT1C sites, respectively) in human and
guinea-pig brain. Qualitative analysis revealed differences in the dis
tributions of [I-125]GTI and [H-3]5-HT binding sites. Regions such as
CA3 and CA4 of the hippocampus, claustrum and putamen showed [H-3]5-HT
binding (under '5-HT1D conditions') but no [I-125]GTI binding sites,
indicating that [H-3]5-HT labels besides a GTI sensitive (5-HT1D) rece
ptor population, a non-5-HT1A/1B/1C/1D[H-3]5-HT binding site in human
and guinea-pig brain. The distribution of these non-5-HT1A/1B/1C/1D[H-
3]5-HT binding sites was studied with [H-3]5-HT under conditions where
5-HT1A, 5-HT1C and 5-HT1D[H-3]5-HT binding sites were saturated by th
e presence of 100 nM 8-OH-DPAT, 100 nM mesulergine and 1 mu M GTI. Sig
nificant densities of these non-5-HT1A/1B/1C/1D sites were observed in
cortical areas, hippocampal structures, nucleus accumbens, amygdala,
caudate-putamen and claustrum. It is concluded that [I-125]GTI does no
t label the 5-HT1E binding site, since all competition curves obtained
with this radioligand were monophasic. By contrast, [H-3]5-HT labels
non-5-HT1A/1B/1C/1D[H-3]S-HT binding sites, but it remains to be estab
lished whether these sites represent a single receptor population.